July 2022 – Page 7 – Iran Cohort Consortium (ICC)

Serum liver enzymes and diabetes from the Rafsanjan cohort study

July 11, 2022/0 Comments/in Publication, Publication, Publication, Publication, Publication, Rafsanjan Youth Cohort Study Publications /by RYCS

Relation of hypertension with episodic primary headaches and chronic primary headaches in population of Rafsanjan cohort study

July 11, 2022/0 Comments/in Rafsanjan Cohort Study Publications /by RACS

Cohort-based analysis of paternal opioid use in relation to offspring’s BMI and plasma lipid profile

July 11, 2022/0 Comments/in Rafsanjan Birth Cohort Study Publications /by RBCS

Profile and baseline data from the Shahrekord PERSIAN Cohort Study

July 10, 2022/0 Comments/in Uncategorized /by SKCS

The prevalence of NCDs was 9.8% for type 2 diabetes, 17.1% for hypertension, 11.6% for thyroid disease, 0.2% for multiple sclerosis and 5.7, 0.9 and 1.3% for ischemic heart disease, stroke and myocardial infarction, respectively. The prevalence of multimorbidity (≥2 NCDs) was higher in women (39.1%) than in men (24.9%). The means (standard deviations) of […]

Hypertension, as a risk factor for cardiovascular diseases, is highly influenced by dietary parameters. This study aims to investigate the possible association of hypertension prevalence and nut consumption.

July 4, 2022/0 Comments/in Rafsanjan Cohort Study News /by RACS

In this cross-sectional study, 9990 participants from the Rafsanjan cohort study, as a part of the prospective epidemiological research studies in IrAN (PERSIAN), aged 35-70 years were included. Nut consumption was assessed using an abbreviated food questionnaire. Further, demography, personal habit, physical activity, medical history, blood pressure, and body mass index (BMI) questionnaires were used. Logistic regression models were applied to examine the possible relationship between hypertension risk and nut consumption. Statistical analyses were performed using STATA statistical software.

The results showed that the average consumption of all nuts except walnuts was significantly higher in non-hypertensive individuals (P<0.001). In the crude regression model, the odds of hypertension were significantly lower among pistachio, walnuts, seeds, and total nuts consumers. However, a protective association was observed between the prevalence of hypertension and the consumption of all nuts together and seeds, after adjusting for sex, age, and other confounders.

The data show that the intake of all nuts and seeds is inversely associated with hypertension risk.